Press release

Top Medical Imaging Company and Provider ofDiagnostic Imaging Collaborate to Elevate
Patient Experience and Lower Cost of CarePrinceton, NJ – December 1, 2021– Guerbet LLC, the US affiliate of Guerbet, a global
leader in medical imaging, announced today that Shields Health Care Group, New
England's largest and most advanced provider of diagnostic imaging, will introduce
Guerbet’s OptiStar® Elite injectors system across their network. This procurement is oneof the largest in Guerbet’s history.
“Guerbet’s reputation for innovation, patient safety, and excellent customer service wereimportant considerations,” says Steve Brune, Field Service Manager of ProCare(Shields’ medical equipment division). “The team at Guerbet is constantly working toimprove and develop new medical imaging solutions to provide better outcomes, better
care, and the best experience for patients, key reasons why this collaboration works forus.”
The OptiStar Elite MR contrast delivery system offers enhancements in:● Workflow efficiency● Battery-free operation● Ability to fill syringes in the control room
● Three mounting options including pedestal, ceiling, and mobileMike Yuja, Guerbet’s Head of Sales in North America, says, “We are proud to partnerwith Shields to provide our OptiStar Elite injectors. The reliability and minimal
maintenance requirements of these devices, as well as the seamless installation
program make them an ideal choice for multi-facility implementation.
80% of the OptiStar Elite injectors ordered have already been installed across Shields’
facilities in New England, with the remaining injectors being installed in early 2022.
About Guerbet
At Guerbet, we build lasting relationships so that we enable people to live better. This is ourpurpose. We are a leader in medical imaging worldwide, offering a wide range of pharmaceuticalproducts, medical devices, digital and AI solutions for diagnostic and interventional imaging. Apioneer since 95 years in the field of contrast media with over 2,600 people globally, we arecontinuously innovating with 10% of revenue dedicated to Research & Development and four1

Press releasecenters in France, Israel, and the United States. Guerbet (GBT) is listed on Euronext Paris(segment B – mid-caps) and generated €712 million in revenue in 2020. For more information,please visit www.guerbet-us.com.
About OptiStar® Elite MR Contrast Delivery System
The OptiStar Elite MR Contrast Delivery System is a Class II Medical Device in the UnitedStates. For complete information about precautions and optimal usage conditions for this device,consult the full instructions for use supplied with each device or with your local Guerbet
representative(s).
Caution: US Federal Law restricts this device to sale by or on the order of a physician.
About Shields Health Care GroupAt Shields, improving lives and elevating performance are at the heart of everything we do.
That’s why more health system leaders trust Shields to help them elevate and scale clinical,
operational, and ﬁnancial performance. Not just within specialty pharmacy, but throughout theentire health system. Working alongside your team, Shields leverages its proven collaborative
care model; integrated care technologies; and dedicated teams to produce the superior
outcomes your patients deserve and the ﬁnancial results your health system demands.
Together, we elevate performance where it matters most — expanding payer and drug access;
improving therapy management and care coordination; delivering unsurpassed patient
experiences, and generating the net operating income you need to accelerate growth. Learn
more about how Shields elevates outcomes and performance at shieldshealthsolutions.com.

2